RxDoctor Payments Data

Lynle Procopio

Family · York, PANPI 1083149413

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,918 of the $3,802 with a category attached, or 76.7%. Impulse Dynamics (USA) Inc. accounts for 63.7% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $2,009, more than ten times the $62 reported in 2021. Among family clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,802in general payments, 2019–2025

Across 66 payments — averaging $57.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Impulse Dynamics (USA) Inc.$2K
  • Boston Scientific$638
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$299
  • Heartflow, Inc.$247
  • E.r. Squibb & Sons, L.L.C.$93
  • Shockwave Medical, Inc$58
  • plus $45 from 1 others

What the payments were for

  • Travel & lodging$88423%
  • Food & beverage$2,91877%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,802 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$17,638
Medicare patients
201
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban504$494,222
XareltoRivaroxaban29$36,342
EntrestoSacubitril/Valsartan17$14,816
Flecainide Acetate219$7,447
Dofetilide28$6,025
Metoprolol Succinate204$3,011
Amiodarone Hcl135$1,377
Eplerenone12$1,179
Midodrine Hcl14$773
SotalolSotalol Hcl27$494
Carvedilol38$410
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$317
Potassium Chloride18$300
Rosuvastatin Calcium29$282
Colchicine13$231

Paid to pharmacies, not to this prescriber.

Other family in York

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →